Skip to main content
. 2023 Nov 30;38(1):274. doi: 10.1007/s00384-023-04570-y

Table 2.

The rate of disease recurrence and residual disease

ER ER+SBR p value
Disease recurrence, n (%) 27 (8.0) 34 (15.5) 0.008
   LNM positive after SBR 15 (11.9)
   Locoregional recurrence 12 (3.5)
   Distant metastases 15 (4.4) 8 (3.7) 0.68
   Upstaged (> T1) CRC after SBR 11 (5.0)*
Residual disease, n (%)
   Yes 21 (9.6)
   No 198 (90.4)

LNM lymph node metastasis

*Excluded from further analysis